ArticleRSC advances2026
Biosynthesis of
Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study was aimed at biosynthesizing silver nanoparticle (AgNP) for remediation of total petroleum hydrocarbon (TPH) from crude oil-contaminated water samples from Nigeria's Niger-Delta ecosystem. The physicochemical and bacteriological analyses of the water samples were ascertained by standard techniques. Screening for hydrocarbon utilization was done for all isolates and the highest degrader was selected for biosynthesis of AgNP and characterized. TPH were adsorbed using the AgNP. The TPH response was designed and optimized using response surface methodology (RSM). The TPH in some of the water samples were above permissible limits in surface water given by Department of Petroleum Resources (DPR) and ranged from 6.55 ± 0.91 to 2324.36 ± 4.23 mg L
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.